Some of the patients with SMAD4 mutations present with another autosomal dominant syndrome, hereditary hemorrhagic telangiectasia (HHT) in which bleeding from arteriovenous malformations (AVMs) may occur. The gene discussed is SMAD4; the disease is hereditary hemorrhagic telangiectasia.